Rule 511-5-5-.03 - Testing Required of Newborn Babies(1) It is the goal of the Department that every baby born alive in Georgia shall be tested for the following conditions, unless its parents or legal guardians object in writing on the ground that such tests and treatment conflict with their religious beliefs:(a) critical congenital heart disease (CCHD);(c) argininosuccinic aciduria;(d) beta-ketothiolase deficiency;(e) biotinidase deficiency;(f) carnitine uptake defect;(h) congenital adrenal hyperplasia;(i) congenital hypothyroidism;(l) glutaric acidemia type I;(o) Krabbe disease as a pilot program beginning September 21, 2021;(p) long-chain acyl-CoA dehydrogenase deficiency;(q) maple syrup urine disease;(r) medium-chain acyl-CoA dehydrogenase deficiency;(s) methylmalonic acidemia;(t) mucopolysaccharidosis type 1;(u) multiple carboxylase deficiency;(y) severe combined immunodeficiency (SCID);(z) sickle cell hemoglobinopathies;(aa) spinal muscular atrophy;(bb) trifunctional protein deficiency;(dd) very long-chain acyl-CoA dehydrogenase deficiency;(ee) x-linked adrenoleukodystrophy;(ff) 3-methylcrotonyl-CoA carboxylase deficiency; and(gg) 3-OH 3-CH3 glutaric aciduria.(2) Unless otherwise noted in subparagraph (1) above, testing for conditions (1)(c) through (gg) shall be conducted through laboratory analysis of the baby's blood on a Newborn Screening Specimen Card as provided in DPH Rule 511-5-5-.04.Ga. Comp. R. & Regs. R. 511-5-5-.03
O.C.G.A. §§ 31-2A-6, 31-12-5 through 31-12-7.
Original Rule entitled "Testing Required of Newborn Babies" adopted. F. May 13, 2014; eff. June 2, 2014.Amended: F. June 14, 2019; eff. July 15, 2019, as specified by the Agency.Amended: F. Nov. 29, 2021; eff. Dec. 29, 2021, as specified by the Agency.Amended: F. Sept. 16, 2024; eff. Oct. 9, 2024, as specified by the Agency.